Mebendazole (CAS 31431-39-7)
Google Keywords: Mebendazole CAS 31431-39-7, Anthelmintic API Manufacturing, Human Deworming Drug Synthesis, Broad-Spectrum Antiparasitic, GMP Pharmaceutical Intermediates
🌟 Product Overview
Mebendazole (CAS 31431-39-7) is a broad-spectrum benzimidazole anthelmintic widely used to treat intestinal parasitic infections in humans and animals. It disrupts parasite microtubule formation, leading to impaired nutrient absorption and eventual death of helminths like roundworms, whipworms, and hookworms.
Primary Function: Key intermediate for synthesizing mebendazole-based APIs with high efficacy against gastrointestinal parasites.
Applications: Human anthelmintic therapies, veterinary deworming solutions, and agricultural parasite management.
✅ Key Advantages
🔹 Ultra-High Purity | ≥99.0% (HPLC/GC verified) | Complies with ICH Q11 guidelines for pharmaceutical intermediates.
🔹 Broad-Spectrum Efficacy | Targets >90% of intestinal parasites in humans and livestock.
🔹 Formulation Flexibility | Stable in oral tablets, suspensions, and chewables for diverse therapeutic needs.
🔹 GMP Compliance | Manufactured under ISO 9001:2015 and ISO 13485 standards, supporting FDA/EMA regulatory filings.
🧪 Applications
Human Anthelmintics: Primary ingredient in deworming medications for ascariasis, trichuriasis, and enterobiasis.
Veterinary Medicine: Used in livestock, poultry, and pet dewormers to control parasitic infestations.
Agricultural Use: Integrated into feed additives to prevent parasitic infections in farming systems.
📜 Quality Assurance
Testing Methods: HPLC, GC, NMR, FTIR, and mass spectrometry for structural validation and impurity profiling.
Standards: Meets USP <1086>, EP 10.0, and ICH stability guidelines for pharmaceutical intermediates.
📈 Market Trends
The global anthelmintics market is expected to grow to $5.2 billion by 2030 (CAGR 4.8%), fueled by high parasitic infection rates in developing regions, rising pet ownership, and demand for cost-effective treatments. Mebendazole remains a first-line therapy due to its proven safety and affordability.
Empower your antiparasitic drug development with Mebendazole – engineered for efficacy, compliance, and scalable production.
China
